Back
Corporate News
Medicamen Biotech to review quarterly, half-year financials at November board meeting
06-Nov-2026, 11:09
Medicamen Biotech Limited will hold a board meeting on November 13, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The trading window for designated persons of the company has been closed since October 1, 2026, and will reopen 48 hours after the financial results are declared.